1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
OTC Pharmaceuticals in the United States

United States: OTC Pharmaceuticals Industry Report

  • September 2016
  • 39 pages
  • ID: 3519909
In this report:
Vitamins and minerals recorded the highest sales value in the US OTC Pharmaceuticals market in 2015, with total sales of $##,##.##m, equivalent to ##.##% of the market's overall value.
The performance of the market is forecast to follow a similar pattern with an anticipated CAGR of ##.##% for the five-year period 2015 - 2020, which is expected to drive the market to a value of $##,##.##m by the end of 2020.

Summary

Table of Contents

Search Inside

Brief

OTC Pharmaceuticals in the US industry profile offers top-line qualitative and quantitative summary information containing: segment market share, market value (value 2011-15, and estimate to 2020). The report also offers details of the top players, including main business metrics and analysis of the competitive environment within the market.

Main highlights

Save time operating entry-level research by identifying the size, increase, main segments, and key players in the otc pharmaceuticals market in the USA

Use the Five Forces analysis to find out the challenging intensity and therefore attractiveness of the otc pharmaceuticals market in the USA

Top companies profiles show details of main otc pharmaceuticals market actors' overall activities and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the United States otc pharmaceuticals market with five year forecasts

Abstract

Fundamental source for important data and analysis covering the United States otc pharmaceuticals market. Contains industry size and segmentation information, textual and graphical study of business growth trends, dominant companies and macroeconomic data.

Great reasons to purchase

What was the dimension of the United States otc pharmaceuticals market worth in 2015?

What is the projected dimension of the United States otc pharmaceuticals market in 2020?

What elements influence the competition forces in the United States otc pharmaceuticals market?

What has performance of the market been during these last 5 years?

Who are the key players in the USA' otc pharmaceuticals market?

Key Findings

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin and other analgesics), medicated skin products (anti-bacterials, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters and bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued in accordance with the RSP and includes taxes. Any currency conversions used in the creation of this report have been counted using constant 2015 annual average exchange rates.

The US OTC pharmaceuticals market performed global revenues of $38,718.7m in 2015, exhibiting a compound annual growth rate (CAGR) of 2.50 percent in the timespan 2011-2015.

Vitamins and minerals reported the more important sales value in the US OTC Pharmaceuticals market in 2015, with global sales of $11,894.0m, equivalent to 30.70 percent of the segment's global value.

The USA spends nearly spends around 16.90 percent of its GDP on healthcare according to the recent figures.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Amrita helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Consumer Health in China

Consumer Health: In-depth Industry Report in China

  • $ 2635
  • Industry report
  • October 2017
  • by Euromonitor International

Heavily influenced by modern lifestyles, consumer health in China maintained strong growth in 2017. On the one hand, hectic schedules, as well as growing societal and work pressures, boosted demand fo ...

Infectious Diarrhea Global Clinical Trials Review, H2, 2017

Clinical Research in Infectious Diarrhea in H2, 2017

  • $ 2500
  • Industry report
  • October 2017
  • by GlobalData

Infectious Diarrhea Global Clinical Trials Review, H2, 2017SummaryGlobalData’s clinical trial report, “Infectious Diarrhea Global Clinical Trials Review, H2, 2017" provides an overview of Infectious ...

Insomnia Global Clinical Trials Review, H2, 2017

Clinical Research in Insomnia in H2, 2017

  • $ 2500
  • Industry report
  • October 2017
  • by GlobalData

Insomnia Global Clinical Trials Review, H2, 2017SummaryGlobalData’s clinical trial report, “Insomnia Global Clinical Trials Review, H2, 2017" provides an overview of Insomnia clinical trials scenario. ...

OTC Drugs Markets in China $ 4000 January 2018


Download Unlimited Documents from Trusted Public Sources

Pharmaceutical Trade in Australia and South Korea - Forecast

  • January 2018
  • Pharmaceutical  

  • Australia  

    South Korea  

View report >

OTC Forecast Statistics in China

  • January 2018
    6 pages
  • China  

    Asia  

View report >

Gastrointestinal Drug Industry

  • January 2018
    11 pages
  • Gastrointestina...  

    Anesthetics  

    Therapy  

View report >

Related Market Segments :

Pharmaceutical

Therapy

Vaccine

Healthcare

ref:plp2016

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.